In 2018, clinical research on cannabidiol included preliminary studies of anxiety, cognition, movement disorders, and pain'.
Ngo-2018, ucwaningo lomtholampilo nge-cannabidiol lufake nezifundo zokuqala zokukhathazeka, ukuqonda, ukuphazamiseka kokuhamba, nobuhlungu.